SYK, ZBH
Stryker Corporation
Healthcare, Event Driven/Special Sit
02/25/2015
Presented
| Date | 02/20/2015 |
| Price | $95.25 |
| Market Cap | $36.10B |
| Ent Value | $35.05B |
| P/E Ratio | 70.34x |
| Book Value | $22.74 |
| Div Yield | 1.5% |
| Shares O/S | 378.75M |
| Ave Daily Vol | 1 |
| Short Int | 1.06% |
Current
| Price | $358.98 |
| Market Cap | $136.80B |
| Stryker Corporation, together with its subsidiaries, operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment offers implants used in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment provides surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling and emergency medical equipment, and reprocessed and remanufactured medical devices, as well as other medical device products for use in various medical specialties. The Neurotechnology and Spine segment offers neurosurgical and neurovascular devices that include products used for minimally invasive endovascular techniques; products for traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also develops, manufactures, and markets spinal implant products, including cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company markets its products to doctors, hospitals, and other healthcare facilities in the United States; and sells its products through company-owned sales subsidiaries and branches, as well as third-party dealers and distributors in approximately 100 countries internationally. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan. |
Publicly traded companies mentioned herein: Smith & Nephew PLC (SNN; SN/ LN), Stryker Corp (SYK), Zimmer Holdings Inc (ZBH)
Highlights
The presenter forecasts further consolidation in the medical devices sector, and thinks both Stryker (SYK) and Zimmer (ZBH) stand to benefit. In the near-term, the closing of the ZBH-Biomet deal should drive up ZBH share prices, and could act as a catalyst for further industry consolidation. He believes SYK shares will likely see positive movement after the ZBH deal closes as investors evaluate the potential merits of a transaction with Smith & Nephew.
◆Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.
◆Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.